Aortic aneurysm surgery: long-term patency of the reimplanted intercostal arteries.

BACKGROUND: During aortic surgery, the long-term patency of reimplanted intercostal arteries is unknown, limiting the relevance to preserve spinal cord vascularization. METHODS: Between January 2001 and January 2007, 40 patients were operated for either thoracic aortic aneurysm (TAA) or thoracoabdominal aortic aneurysm (TAAA). Twenty cases of aneurysms limited to the proximal descending thoracic aorta were treated using endovascular repair, without preoperative spinal cord artery identification. Twenty patients--seven with extensive TAA, seven with type I TAAA, two with type II TAAA, and four with type III TAAA--underwent open surgery. Before open surgery, preoperative angiography was performed to identify spinal cord vascularization; in one case, the angiography failed to identify it. The segmental artery destined to the spinal cord artery was identified as originating from outside the aneurysm in 7 patients and inside the aneurysm in 12 patients: T6 R (1), T8 L (2), T9 L (3), T10 L (3), T11 L (3), L1 L (1). During the surgery, normothermic and femorofemoral bypass was used for visceral protection. All segmental arteries identified as critical before surgery were reattached in the graft. Twenty-four months later, computed tomography scans were performed to assess the patency of the reattached segmental arteries. RESULTS: Three patients died, including one with paraplegia (T9 L). No other cases of paraplegia were reported. Computed tomography scans were performed in 10 patients. Segmental artery reattachment was patent in nine patients. CONCLUSION: Our experience indicates the long-term patency of reimplanted segmental artery, without any convincing evidence of its utility in preventing neurologic events during TAA and TAAA direct repair.

Impact of preoperative staging with contrast-enhanced mammography for localized breast cancer management.

OBJECTIVE: A precise evaluation of the disease extent is mandatory before surgery for early breast cancer (EBC). Contrast-enhanced mammography (CEDM) is a recent technique that may help define adequate surgery. METHODS: This retrospective study included consecutive patients referred to a cancer center between November 2016 and July 2017 for biopsy-confirmed invasive EBC management. The primary objective was to evaluate the rate of surgical changes after incorporating the results of the preoperative staging examination, including CEDM. RESULTS: A total of 231 patients were screened for inclusion, and 132 patients were included, corresponding to 134 lesions. The first surgical plan was modified for 33 patients (25%), which represented 34 lesions. For 8 patients (6%), the surgery was cancelled in preference for neoadjuvant chemotherapy; for 16 patients (12.1%), the primary tumor procedure was enlarged; and for 23 patients (17.4%) the lymph node management was modified. Surgery was changed only due to the CEDM results for 24 patients (18.5%) and consisted of a more invasive procedure due to a more extended, multifocal or multicentric lesion than seen on the standard imaging. Anatomopathological surgery piece findings were well correlated with contrast-enhanced mammography results. Overall, there was no increase in the delay between the planned date of surgery and the effective surgical procedure (median 0 days). CONCLUSION: CEDM added to preoperative staging helped define better surgical management without increasing delay in the surgical procedure. ADVANCES IN KNOWLEDGE: CEDM is a reliable technique that should be considered as part of preoperative staging for EBC.

Usefulness of multislice computerized tomographic angiography in the postoperative evaluation of patients with clipped aneurysms.

BACKGROUND: The aim of our study was to evaluate the diagnostic efficacy of multislice computed tomographic angiography (MSCTA) regarding exclusion quality after aneurysm clipping. METHODS: Sixty patients (74 aneurysms) underwent microsurgical exclusion using titanium clips. The presence of aneurysm remnants on MSCTA was compared by a neuroradiologist to 2D digital subtraction angiography (DSA), which was considered as a reference examination. The contribution of 3D DSA was assessed in a subpopulation of 29 patients (35 aneurysms). RESULTS: With 2D DSA, six aneurysm remnants (8%) were diagnosed, and only five (7%) by MSCTA. The specificity and sensitivity were 98.5 and 83%, respectively. MSCTA failed to demonstrate one large remnant (>2 mm) because of clip artifacts (six clips). With 3D DSA six supplementary remnants were diagnosed. Two were large remnants blinded by vessel overlaps and clip artifacts. Four were small "dog-eared" remnants (< or =2 mm). No additional treatment was required for small remnants. CONCLUSION: In the postoperative period, MSCTA was considered a useful tool to evaluate the large remnants as well as a non-invasive ulterior examination for suspected bifurcation. Nevertheless, 3D DSA is still required for an accurate evaluation of aneurysms treated by more than three clips.

Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials.

BACKGROUND AND PURPOSE: Although MRI is increasingly proposed to investigate composition of carotid atherosclerosis, its reproducibility has rarely been addressed. We assessed the reproducibility of MRI for the identification and quantification of carotid atherosclerotic plaque components. METHODS: Using published criteria, 2 readers independently analyzed the carotid MRI (1.5-T MR units with a 4-channel phased-array surface coil, Machnet) of 85 consecutive patients with symptomatic (40% to 69% according to NASCET method) or asymptomatic (60% or greater) carotid artery stenosis enrolled in an ongoing prognostic study. One reader reevaluated all images. Fibrous cap was also secondarily identified independently on T2-weighted and time-of-flight (TOF) images. RESULTS: Intraobserver agreement was substantial for the identification of calcifications (kappa [kappa]=0.70; 95% CI: 0.54 to 0.86) and lipid-rich/necrotic core (LR/NC) (kappa=0.69; 0.31 to 0.86), almost perfect for hemorrhages (kappa=0.82; 0.68 to 0.96), and moderate (kappa=0.58; 0.27 to 0.88) and fair (kappa=0.33; 0.09 to 0.56) for fibrous cap identification on T2-weighted and TOF images, respectively. Interobserver agreement was substantial for the identification of calcifications (kappa=0.74; 0.59 to 0.89) and hemorrhages (kappa=0.62; 0.43 to 0.81), and moderate for LR/NC (kappa=0.58; 0.20 to 0.95). Agreement was fair for fibrous cap identification on both T2-weighted (kappa=0.28; -0.03 to 0.59) and on TOF images (kappa=0.26; 0.04 to 0.48). Agreement between T2 and TOF images for fibrous cap identification was slight (kappa=0.16; 0.01 to 0.31). Intra- and interobserver reproducibility for quantitative area measurements of vessel, lumen, plaque, LR/NC, and fibrous components was high with intraclass correlation coefficients ranging from 0.73 to 0.99. However, for the LR/NC, the interval delimited by the Bland-Altman graphs was wide in comparison to the mean. CONCLUSIONS: Vessel and plaque quantification is reproducible. Reproducibility of MRI for identifying and quantifying carotid plaque components is overall acceptable, but there is still significant variability that should be taken into account in the design of prognosis studies and clinical trials. Reproducibility for fibrous cap identification needs to be improved.

[Treatment of aneurysmal subarachnoid hemorrhage]. / Traitement de l'hémorragie méningée anévrismale.

The incidence of subarachnoid hemorrhages is about 10.5/100,000 persons/year. Early obliteration of the aneurysmal sac is necessary to avoid rebleeding. The neurovascular staff meeting must decide the appropriate obliteration procedure for each patient. Intraoperative morbidity is 8% after endovascular coiling and 10% after microsurgical clipping. Endovascular coiling leads to complete obliteration of the aneurysm in 60% of patients and microsurgical clipping in 95%. Delayed ischemic deficits may be prevented by volemic expansion and calcium channel blockers. Hospitalization and general prophylaxis against deep venous thrombosis, pain and seizures are essential. Curative treatment is required against common complications such as intraparenchymatous hematoma, hydrocephalus, and delayed ischemic deficit.